News

Quiver Quantitative
quiverquant.com > news > New+Bill%3A+Senator+Richard+Blumenthal+introduces+S.+4149%3A+Social+Determinants+for+Moms+Act

New Bill: Senator Richard Blumenthal introduces S. 4149: Social Determinants for Moms Act | Stock News

3+ hour, 27+ min ago  (346+ words) We have received text from S. 4149: Social Determinants for Moms Act. This bill was received on 2026-03-19, and currently has 2 cosponsors. The Secretary of Health and Human Services is required to convene a task force that includes representatives from various government departments,…...

Quiver Quantitative
quiverquant.com > news > Press+Release%3A+Underwood%2C+Adams%2C+and+Booker+Reintroduce+Comprehensive+Legislation+to+Address+Maternal+Health+Crisis+in+the+U.S.

Press Release: Underwood, Adams, and Booker Reintroduce Comprehensive Legislation to Address Maternal Health Crisis in the U.S. | Stock News

1+ week, 1+ day ago  (395+ words) Representatives Underwood, Adams, and Senator Booker reintroduce the Momnibus, a legislative package to address maternal health crises. Legislators reintroduce the Momnibus: Representatives Lauren Underwood and Alma Adams, alongside Senator Cory Booker, have reintroduced the Momnibus, comprising 14 bills aimed at addressing…...

Quiver Quantitative
quiverquant.com > news > Greenwich+LifeSciences%2C+Inc.+Announces+Presentation+of+FLAMINGO-01+Phase+III+Clinical+Trial+Data+at+AACR+Meeting+2026

Greenwich LifeSciences, Inc. Announces Presentation of FLAMINGO-01 Phase III Clinical Trial Data at AACR Meeting 2026 | GLSI Stock News

1+ week, 2+ day ago  (454+ words) Greenwich LifeSciences announced presentations at AACR 2026 for its Phase III trial evaluating GLSI-100 immunotherapy in breast cancer patients. FLAMINGO-01 is a Phase III clinical trial assessing the efficacy of GLSI-100 immunotherapy in preventing breast cancer recurrences. The AACR Meeting 2026 will…...